Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wuchan Zhongda Geron is a specialized healthcare subsidiary of the Wuchan Zhongda Group, a prominent Chinese state-owned Fortune Global 500 enterprise. The company focuses on the "Great Health" sector, specifically targeting the aging population through integrated medical-nursing services and elderly care community development. It operates various senior living facilities, rehabilitation centers, and health management platforms, primarily within the Zhejiang province. Beyond direct care services, the company leverages its parent group's supply chain expertise to engage in medical equipment procurement and healthcare infrastructure investment. Wuchan Zhongda Geron aims to build a comprehensive ecosystem that combines professional medical treatment with community-based support for the elderly.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wuchan Zhongda Geron.